Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis
Cancer Immunology, Immunotherapy · Published 2023-04-01 · Available online 31 Oct 2022 · Journal article · DOI 10.1007/s00262-022-03287-1 · PMID: 36315268 · PMC · Cited by 29 (Crossref)
Authors (4)
Kathryn Owen, Ramy Ghaly, Kyrillus S. Shohdy, Fiona Thistlethwaite
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Volume
- 72
- Issue
- 4
- Pages
- 805-814
- Year
- 2023
Citation
Owen, K., Ghaly, R., Shohdy, K., et al. (2023). Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-022-03287-1
Related articles
- The evolution of cellular therapies in sarcoma: Breakthroughs, challenges, and future directions · Human Vaccines & Immunotherapeutics · 2026 · Cites or is cited by this article
- Breathing new life into T-cell receptor-engineered T-cell therapy in solid tumors: enhancing strategies to expand the universality of precision therapy · Experimental Hematology & Oncology · 2026 · Cites or is cited by this article
- HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · Cancer Immunology, Immunotherapy · 2026 · Same journal
- Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
- Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
- Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
- Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
- Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · Cancer Immunology, Immunotherapy · 2026 · Same journal
- Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions · Cancer Immunology, Immunotherapy · 2026 · Same journal
- Efficacy and safety of anti-PD-1 combined with IFN-α1b with or without anlotinib as the first-line therapy in patients with unresectable advanced melanoma: a real-world cohort study · Cancer Immunology, Immunotherapy · 2026 · Same journal
Metrics
- Citations (Crossref)
- 29